Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | REVB Stock News
I'm PortAI, I can summarize articles.
Revelation Biosciences, Inc. (NASDAQ:REVB) announced an inducement grant of 90,000 restricted stock units (RSUs) to a new non-executive employee, approved by its Compensation Committee on January 8, 2026. This grant, made outside the stockholder-approved equity incentive plan, is in accordance with Nasdaq Listing Rule 5635(c)(4) and will vest over two years in quarterly installments, contingent on the employee's continued service. Revelation focuses on rebalancing inflammation with its proprietary formulation, Gemini, and has ongoing programs for various medical conditions.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: StockTitan The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments